Molecular epidemiology and socio-demographic risk factors of sexually transmitted infections among women in Lebanon.
Adult
Cervix Uteri
/ microbiology
Chlamydia trachomatis
/ genetics
Cross-Sectional Studies
Female
Gardnerella vaginalis
/ genetics
Humans
Lebanon
/ epidemiology
Male
Molecular Epidemiology
Mycoplasma Infections
/ epidemiology
Mycoplasma genitalium
/ genetics
Mycoplasma hominis
/ genetics
Neisseria gonorrhoeae
/ genetics
Papillomaviridae
/ genetics
Risk Factors
Sexually Transmitted Diseases
/ epidemiology
Trichomonas vaginalis
/ genetics
Ureaplasma
/ genetics
Vagina
/ microbiology
Vaginal Smears
Young Adult
Clinical symptoms
HPV genotyping
Molecular detection
Risk factors
STIs
Surveillance
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
27 May 2020
27 May 2020
Historique:
received:
19
12
2019
accepted:
03
05
2020
entrez:
29
5
2020
pubmed:
29
5
2020
medline:
1
8
2020
Statut:
epublish
Résumé
Sexually transmitted infections (STIs) cause a major public health problem that affect both men and women in developing and developed countries. The aim of the study was to estimate the prevalence of 11 STIs among women who voluntarily participated in the study, while seeking gynecological checkup. The existence of an association between the presence of pathogens and symptoms and various sociodemographic risk factors was assessed. A total of 505 vaginal and cervical specimens were collected from women above 18 years of age, with or without symptoms related to gynecological infections. Nucleic acid was extracted and samples were tested by real-time PCR for the following pathogens: Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Ureaplasma urealyticum, Urealplasma parvum, Trichomonas vaginalis, Mycoplasma hominis, Mycoplasma girerdii, Gardnerella vaginalis, Candida albicans and Human Papillomavirus (HPV). Positive HPV samples underwent genotyping using a microarray system. Of the 505 samples, 312 (62%) were screened positive for at least one pathogen. Of these, 36% were positive for Gardnerella vaginalis, 35% for Ureaplasma parvum, 8% for Candida albicans, 6.7% for HPV, 4.6% for Ureaplasma urealyticum, 3.6% for Mycoplasma hominis, 2% for Trichomonas vaginalis, 0.8% for Chlamydia trachomatis, 0.4% for Mycoplasma girerdii, 0.2% for Mycoplasma genitalium and 0.2% for Neisseria gonorrhoeae. Lack of symptoms was reported in 187 women (37%), among whom 61% were infected. Thirty-four samples were HPV positive, with 17 high risk HPV genotypes (HR-HPV); the highest rates being recorded for types 16 (38%), 18 (21%) and 51 (18%). Out of the 34 HPV positives, 29 participants had HR-HPV. Association with various risk factors were reported. This is the first study that presents data about the presence of STIs among women in Lebanon and the MENA region by simultaneous detection of 11 pathogens. In the absence of systematic STI surveillance in Lebanon, concurrent screening for HPV and PAP smear is warranted.
Sections du résumé
BACKGROUND
BACKGROUND
Sexually transmitted infections (STIs) cause a major public health problem that affect both men and women in developing and developed countries. The aim of the study was to estimate the prevalence of 11 STIs among women who voluntarily participated in the study, while seeking gynecological checkup. The existence of an association between the presence of pathogens and symptoms and various sociodemographic risk factors was assessed.
METHODS
METHODS
A total of 505 vaginal and cervical specimens were collected from women above 18 years of age, with or without symptoms related to gynecological infections. Nucleic acid was extracted and samples were tested by real-time PCR for the following pathogens: Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Ureaplasma urealyticum, Urealplasma parvum, Trichomonas vaginalis, Mycoplasma hominis, Mycoplasma girerdii, Gardnerella vaginalis, Candida albicans and Human Papillomavirus (HPV). Positive HPV samples underwent genotyping using a microarray system.
RESULTS
RESULTS
Of the 505 samples, 312 (62%) were screened positive for at least one pathogen. Of these, 36% were positive for Gardnerella vaginalis, 35% for Ureaplasma parvum, 8% for Candida albicans, 6.7% for HPV, 4.6% for Ureaplasma urealyticum, 3.6% for Mycoplasma hominis, 2% for Trichomonas vaginalis, 0.8% for Chlamydia trachomatis, 0.4% for Mycoplasma girerdii, 0.2% for Mycoplasma genitalium and 0.2% for Neisseria gonorrhoeae. Lack of symptoms was reported in 187 women (37%), among whom 61% were infected. Thirty-four samples were HPV positive, with 17 high risk HPV genotypes (HR-HPV); the highest rates being recorded for types 16 (38%), 18 (21%) and 51 (18%). Out of the 34 HPV positives, 29 participants had HR-HPV. Association with various risk factors were reported.
CONCLUSIONS
CONCLUSIONS
This is the first study that presents data about the presence of STIs among women in Lebanon and the MENA region by simultaneous detection of 11 pathogens. In the absence of systematic STI surveillance in Lebanon, concurrent screening for HPV and PAP smear is warranted.
Identifiants
pubmed: 32460721
doi: 10.1186/s12879-020-05066-8
pii: 10.1186/s12879-020-05066-8
pmc: PMC7251815
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
375Références
J Low Genit Tract Dis. 2012 Apr;16(2):106-20
pubmed: 22371041
PLoS One. 2018 May 1;13(5):e0196516
pubmed: 29715319
Am J Obstet Gynecol. 1986 Mar;154(3):556-64
pubmed: 3485379
Indian J Med Res. 2013 Sep;138(3):303-16
pubmed: 24135174
Rev Epidemiol Sante Publique. 2018 Feb;66(1):1-6
pubmed: 29249573
Ann Biol Clin (Paris). 2018 Aug 1;76(4):459-476
pubmed: 30078782
Clin Infect Dis. 2014 Sep 15;59(6):834-41
pubmed: 24928292
Lancet. 2007 Jun 9;369(9577):1961-71
pubmed: 17560449
J Obstet Gynaecol. 2011;31(3):237-41
pubmed: 21417648
Am J Obstet Gynecol. 2017 Jan;216(1):1-9
pubmed: 28007229
Gynecol Oncol. 2017 Jul;146(1):196-204
pubmed: 28442134
Infect Dis Obstet Gynecol. 2016;2016:5758387
pubmed: 27366021
Curr Opin Microbiol. 2017 Dec;40:58-64
pubmed: 29132066
J Infect Dev Ctries. 2012 Sep 17;6(9):680-3
pubmed: 23000869
Bull World Health Organ. 2019 Aug 1;97(8):548-562P
pubmed: 31384073
Bull World Health Organ. 2003;81(9):639-45
pubmed: 14710505
Sex Transm Infect. 2010 Aug;86(4):263-70
pubmed: 20660590
Vaccine. 2018 Aug 28;36(36):5416-5423
pubmed: 28801154
Infection. 2017 Aug;45(4):469-477
pubmed: 28260146
Scand J Infect Dis. 2014 Sep;46(9):637-41
pubmed: 25017795
Sex Transm Infect. 2013 Sep;89(6):523-7
pubmed: 23605850
Eur J Clin Microbiol Infect Dis. 2016 Jun;35(6):1033-6
pubmed: 27048314
Lancet. 2007 Sep 8;370(9590):890-907
pubmed: 17826171
Annu Rev Sex Res. 2000;11:92-124
pubmed: 11351836
MMWR Morb Mortal Wkly Rep. 2014 Sep 26;63(38):834-8
pubmed: 25254560
Lancet. 2013 Nov 30;382(9907):1795-806
pubmed: 24286785
Cancer Cytopathol. 2017 Oct;125(10):795-805
pubmed: 28817235
Am J Obstet Gynecol. 2016 Jan;214(1):15-21
pubmed: 26164695
J Clin Microbiol. 1997 Jun;35(6):1304-10
pubmed: 9163434
J Clin Microbiol. 2007 Aug;45(8):2649-53
pubmed: 17567790
Vaccine. 2013 Dec 30;31 Suppl 6:G45-50
pubmed: 24331819
BMC Public Health. 2014 Jul 01;14:671
pubmed: 24981921
Am J Health Behav. 2012 Jul;36(4):505-12
pubmed: 22488400
Vaccine. 2012 Nov 20;30 Suppl 5:F192-200
pubmed: 23199963
Lancet Oncol. 2012 Jun;13(6):607-15
pubmed: 22575588
BMC Womens Health. 2015 Apr 01;15:31
pubmed: 25887145
J Adolesc Health. 2008 Oct;43(4 Suppl):S5-25, S25.e1-41
pubmed: 18809145
Hum Reprod Update. 1999 Sep-Oct;5(5):433-47
pubmed: 10582782
Contraception. 2006 Feb;73(2):145-53
pubmed: 16413845
Future Microbiol. 2016;11(4):567-83
pubmed: 27070839
Semin Neonatol. 2000 Aug;5(3):255-69
pubmed: 10956450
Int J STD AIDS. 1997 Aug;8(8):501-5
pubmed: 9259498
J Infect Dis. 2010 Dec 15;202(12):1789-99
pubmed: 21067372
Clin Microbiol Rev. 2017 Jul;30(3):811-825
pubmed: 28539504
Lancet Glob Health. 2019 Sep;7(9):e1197-e1225
pubmed: 31402004
Diagn Cytopathol. 2017 Jul;45(7):580-586
pubmed: 28436211
Sex Transm Dis. 2008 Jun;35(6):607-10
pubmed: 18434942
Cult Health Sex. 2013;15(5):570-82
pubmed: 23730919
Biomed Res Int. 2016;2016:9315757
pubmed: 27144177
Sex Transm Infect. 2013 Nov;89 Suppl 3:iii57-60
pubmed: 23863874
Alcohol Clin Exp Res. 2008 Nov;32(11):2008-15
pubmed: 18782336
Diagn Microbiol Infect Dis. 2016 Jul;85(3):318-322
pubmed: 27156793